Pancreatic Neoplasms
Showing NaN - NaN of 10
Pancreatic Tumors Trial in Worldwide (Contrast-enhanced Diffusion-weighted MRI)
Recruiting
- Pancreatic Neoplasms
- Contrast-enhanced Diffusion-weighted MRI
-
Athens, Greece
- +6 more
Sep 19, 2021
Spanish Series of Patients Treated With Radionuclide Lutetium177
Recruiting
- Neuroendocrine Tumors
- +17 more
- Lutetium [177Lu] oxodotreotide/dotatate
-
Santiago De Compostela, A Coruña, Spain
- +18 more
Jul 1, 2021
Neuroendocrine Tumors, Pancreatic Tumors Trial in Spain (TH-302 + Sunitinib)
Completed
- Neuroendocrine Tumors
- Pancreatic Neoplasms
- TH-302 + Sunitinib
-
L'Hospitalet de Llobregat, Barcelona, Spain
- +9 more
Jul 9, 2020
Pancreatic Cancer, Pancreatic Tumors Trial in Madrid (Intermittent aspiration)
Completed
- Pancreatic Cancer
- Pancreatic Neoplasms
- Intermittent aspiration
-
Madrid, SpainHospital Universitario de la Princesa
May 21, 2020
Pancreatic Tumors Trial in Worldwide (nab-Paclitaxel, Gemcitabine, Chemoradiation)
Pancreatic Tumors Trial in Worldwide (LY2603618, Gemcitabine)
Completed
- Pancreatic Neoplasms
-
Jacksonville, Florida
- +29 more
Mar 15, 2018
Pancreatic Tumors Trial in Worldwide (Larotaxel (XRP9881), 5-Fluorouracil, Capecitabine)
Completed
- Pancreatic Neoplasms
- Larotaxel (XRP9881)
- +2 more
-
Bridgewater, New Jersey
- +20 more
May 3, 2016
Ovarian Tumors, Pancreatic Tumors, Colorectal Tumors Trial in Worldwide (CNTO 328; Anti-interleukin-6 mAb)
Completed
- Ovarian Neoplasms
- +4 more
- CNTO 328; Anti-interleukin-6 monoclonal antibody
-
Philadelphia, Pennsylvania
- +11 more
May 13, 2014
Islet Cell Carcinoma, Neuroendocrine Carcinoma, Neuroendocrine Tumor Trial in Worldwide (Everolimus 10 mg, Octreotide Depot)
Completed
- Islet Cell Carcinoma
- +3 more
- Everolimus 10 mg
- Octreotide Depot
-
Birmingham, Alabama
- +53 more
May 6, 2013